BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.58
+$0.63 (+0.84%)
Nov 2, 2026, 12:53 PM ET · Market open
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 945.54M | 713.07M | 579.96M | 502.08M | 353.78M | 235.81M | 127.42M | 221.9M | 217.77M | 219.12M | 218.6M | 9.3M | 9.43M | 5.68M | 77.78M | 77.65M | 88.66M | 90.67M | 70.95M | 69.72M | 56.95M | 62.74M | 8.71M |
Cost of Revenue | 61.34M | 47.45M | 36.06M | 28.27M | 14.94M | 8.97M | 5.92M | 3.88M | 2.39M | 2.39M | 2.39M | 2.45M | 2.5M | 2.64M | 2.74M | 3.43M | 4.34M | 5.05M | 4.46M | 3.11M | 1.56M | 109K | n/a |
Gross Profit | 884.2M | 665.62M | 543.9M | 473.81M | 338.84M | 226.84M | 121.5M | 218.02M | 215.37M | 216.73M | 216.2M | 6.86M | 6.93M | 3.04M | 75.04M | 74.21M | 84.33M | 85.62M | 66.49M | 66.6M | 55.39M | 62.63M | 8.71M |
Operating Income | -409.91M | -543.47M | -570.67M | -569.09M | -609.88M | -656.43M | -697.69M | -592.97M | -544.36M | -510.3M | -480.86M | -607.37M | -559.19M | -530.61M | -464.69M | -512.2M | -548.58M | -568.97M | -582.81M | -576.63M | -538.51M | -508.95M | -539.5M |
Interest Income | 30.34M | 23.48M | 20.72M | 19.85M | 20.21M | 17.26M | 18.56M | 17.25M | 18.14M | 18.64M | 17.96M | 18.04M | 16.55M | 15.18M | 11.43M | 7.54M | 3.63M | 1.45M | 1.01M | 1.13M | 1.4M | 1.86M | 2.47M |
Pretax Income | -578.95M | -706.17M | -731.93M | -734.99M | -803.98M | -781.76M | -675.64M | -542.19M | -446.29M | -461.52M | -546.68M | -653.25M | -623.49M | -584.2M | -426.05M | -484.65M | -496.36M | -517.19M | -616.7M | -586.45M | -569.2M | -538.35M | -572.49M |
Net Income | -570.21M | -696.24M | -725.93M | -729.31M | -797.12M | -776.42M | -667.97M | -535.76M | -438.86M | -453.82M | -538.26M | -643.2M | -612.65M | -572.99M | -424.94M | -481.18M | -490.77M | -509.37M | -595.86M | -562.54M | -535.34M | -495.27M | -519.95M |
Selling & General & Admin | 733.01M | 669.78M | 612.67M | 555.14M | 467.92M | 399.12M | 329.49M | 288.93M | 241.73M | 208.69M | 185.29M | 150.59M | 134.87M | 130.28M | 130.58M | 143.19M | 166.08M | 180.97M | 190.52M | 192.21M | 174.9M | 164.83M | 156.83M |
Research & Development | 561.59M | 530.96M | 492.74M | 477.54M | 465.89M | 473.46M | 476.92M | 506.46M | 506.34M | 511.03M | 503.82M | 455.71M | 416.39M | 383.76M | 384.67M | 399.46M | 430.76M | 442.55M | 436.11M | 451.02M | 419M | 406.74M | 391.38M |
Other Expenses | -486K | 8.36M | 9.16M | 10.22M | 14.91M | 10.69M | 12.78M | 15.61M | 11.67M | 7.32M | 7.96M | 7.93M | 14.86M | 19.61M | 24.47M | 43.77M | 36.07M | 31.06M | 22.66M | n/a | n/a | n/a | n/a |
Operating Expenses | 1.29B | 1.21B | 1.11B | 1.04B | 948.72M | 883.27M | 819.18M | 811M | 759.74M | 727.04M | 697.07M | 614.23M | 566.12M | 533.65M | 539.73M | 586.42M | 632.91M | 654.58M | 649.29M | 643.23M | 593.9M | 571.57M | 548.21M |
Interest Expense | 133.63M | 89.83M | 114.19M | 103.52M | 121.34M | 132.66M | 117.96M | 99.29M | 89.74M | 86.98M | 84.64M | 81.29M | 81.01M | 80.53M | 80.22M | 80.44M | 75.58M | 66.82M | 57.38M | 46.78M | 42.61M | 42.47M | 42.38M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.36B | 1.26B | 1.15B | 1.07B | 963.66M | 892.24M | 825.1M | 814.88M | 762.13M | 729.43M | 699.46M | 616.67M | 568.61M | 536.29M | 542.47M | 589.85M | 637.25M | 659.64M | 653.75M | 646.35M | 595.46M | 571.68M | 548.21M |
Income Tax Expense | 1.23M | -1.55M | 555K | 555K | 1.71M | 3.25M | 1.15M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 196.03M | 195.79M | 194.79M | 197.24M | 190.52M | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
Shares Outstanding (Diluted) | 196.03M | 195.79M | 194.79M | 197.24M | 190.52M | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
EPS (Basic) | -3.04 | -3.58 | -3.75 | -3.79 | -4.19 | -4.09 | -3.53 | -2.85 | -2.41 | -2.63 | -3.22 | -3.94 | -4.02 | -3.94 | -3.03 | -3.46 | -3.43 | -3.49 | -4.08 | -3.91 | -3.91 | -3.83 | -4.20 |
EPS (Diluted) | -3.04 | -3.58 | -3.75 | -3.79 | -4.19 | -4.09 | -3.53 | -2.85 | -2.41 | -2.63 | -3.22 | -3.94 | -4.02 | -3.94 | -3.03 | -3.46 | -3.43 | -3.49 | -4.08 | -3.91 | -3.91 | -3.83 | -4.20 |
EBITDA | -440.58M | -611.26M | -612.41M | -626.04M | -677.28M | -643.59M | -551.92M | -436.83M | -350.26M | -368.14M | -455.58M | -565.47M | -535.91M | -497.09M | -339.32M | -397.44M | -414.15M | -445.11M | -552.16M | -533.83M | -521.84M | -491.05M | -527.27M |
EBIT | -445.32M | -616.33M | -617.74M | -631.47M | -682.65M | -649.1M | -557.68M | -442.9M | -356.55M | -374.54M | -462.04M | -571.96M | -542.48M | -503.67M | -345.84M | -404.21M | -420.78M | -450.36M | -559.32M | -539.68M | -526.59M | -495.88M | -530.11M |
Depreciation & Amortization | 4.74M | 5.07M | 5.34M | 5.43M | 5.37M | 5.51M | 5.76M | 6.08M | 6.29M | 6.39M | 6.46M | 6.49M | 6.57M | 6.58M | 6.52M | 6.77M | 6.64M | 5.26M | 7.16M | 5.84M | 4.75M | 4.83M | 2.84M |
Add to Watchlist
Select watchlists to add or remove BBIO